Real Value Shared with the Global Community

Belong
provides

True value for the global
community

Belong provides true value for the global community

Revealing hidden patterns using Belong’s proprietary, multi-layered data powered by machine learning & artificial intelligence to advance clinical research and improve patient quality of life and care.

For patients, caregivers, health professionals, providers and pharma.

We are deeply committed to advancing the state of global research with quality, real-world data.

Leveraging AI & ML
for a Hyper-Personalized
Experience

Cutting-edge AI, machine learning and proprietary medical
neural networks are changing the way we and our partners
understand patient journeys.

Why Conduct Research With Belong?

Highly engaged patients
Disruptive analytics technologies
Unparalleled real-world data​​

Belong.life Can Help You Accelerate Cancer Research

By understanding real-life treatment journeys, analyzing critical decision points, conducting surveys and providing you with competitive Business Intelligence.

Recent Studies

We have made significant contributions to global cancer research, having published several papers in leading international peer-reviewed journals.

Clinical Trials Participation Is Directly Influenced By The Information Received By Cancer Patients (Pts) A Caregivers: Real-World Evidence With The Use Of A Specialized Digital Health Platform. (Abstract E24118)

Evaluating The Dyadic Management Of Sexuality-Related Parameters In Women With Early Breast Cancer (EBC): The Emergence Of “Partner Reported Outcome Measurements”. (Abstract E18779)

Researched by Belong.Life and published by ASCO
1069 patients, users of Belong.life, a worldwide, free, and voluntary, digital health application,
replied during April 2021 to a targeted survey including demographic & clinical questions
related to their cancer status, ongoing therapies and the received Covid 19 vaccination details

2020
Social media platforms give patients a voice by allowing them to discuss their health and connect with others. These unfiltered and genuine reports offer direct access to what matters most to patients. Exploring the patient-reported outcomes discussed in these platforms reveal clinical insights and behavioral patterns of the real-world patient journey. This research study reviewed health-related quality of life (HRQoL) concepts reported by patients with multiple myeloma (MM).

Belong.Life is a leading global tech provider of high-engagement patient communities and care platforms, supporting millions of patients worldwide.

Among Belong.Life’s brands are the world’s largest social and professional networks for cancer patients (Belong – Beating Cancer Together) and multiple sclerosis patients (BelongMS), as well as i-Belong, BelongIBD, BelongPSOCoronApp (in selected countries), and more.

Belong.Life’s mission is to improve quality of life and quality of care worldwide through technology, engagement, data, and AI.

Skip to content